ArticleOncoTargets and therapy2021

Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review.

Chunmei Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.